Youth depression and suicide: Selective serotonin reuptake inhibitors treat the former and prevent the latter

Canadian Journal of Psychiatry

Volumn 54, Issue 2, 2009, Pages 76-77

  Brent, David A ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

CHEMOPROPHYLAXIS; CHILD HEALTH; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; GROUPS BY AGE; HUMAN; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SHORT SURVEY; SUICIDE;

EID: 60849117809     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370905400204     Document Type: Short Survey

References (6)

1. Bridge J, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2001;291:1683-1696.
2. Bridge JA, BirmaherB, Iyengar S, et al. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry. 2009 Jan; 166(1):42-49.
3. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163:41-41.
4. Rutz W. Preventing suicide and premature death by education and treatment. J Affect Disord. 2001;62:123-129.
5. Szanto K, Kalmar S, Hendin H, et al. A suicide prevention program in a region with a very high suicide rate. Arch Gen Psychiatry. 2001;64:914-920.
6. Brent DA, Baugher M, Bridge J, et al. Age and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry. 1999;38:1491-1505.